Advertisement
Advertisement

TFFP

TFFP logo

Tff Pharmaceuticals Inc

0.0646
USD
-0.0981
-60.30%
Dec 12, 15:55 UTC -5
Open

Tff Pharmaceuticals Inc Profile

About

TFF Pharmaceuticals Inc. is an early-stage biopharmaceutical company. It is focused on the development and commercialization of inhalation products for the treatment of chronic respiratory diseases and lung conditions. TFF Pharmaceuticals Inc. is based in Austin, Texas.

Info & Links

CEO

Harlan Weisman

Headquarters

1751 River Run, Suite 400
Fort Worth, TX 76107, UNITED STATES

Auditor

Marcum llp

Share holders

6

Employees

19

Tff Pharmaceuticals Inc Statistics

Valuation Measures

Market Capitalization2

286.82K

Enterprise Value

-4.10M

Enterprise Value/EBITDA(ttm)

0.22

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

0.25

Price to Book(mrq)

0.07

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-1596.64%

Profit Margin(ttm)

-2377.23%

Return on Equity(ttm)

-310.17%

Return on Invested Capital(ttm)

-347.11%

Return on Assets(ttm)

-196.06%

Income Statement

Revenue(ttm)

1.20M

Revenue Per Share(ttm)

0.35

Gross Profit(ttm)

1.20M

EBITDA(ttm)3

-19.01M

Net Income Available to Common(ttm)

-19.39M

Diluted EPS(ttm)

-6.44

Share Statistics

Beta (5Y Monthly)

1.07

52-Week Change

-99.31%

S&P 500 52-Week Change

26.61%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

3.47M

Dividend Yield

0.00%

Float4

4.24M

% Held by Insiders

4.50%

% Held by Institutions

15.25%

Balance Sheet

Total Cash(mrq)

4.39M

Total Cash Per Share(mrq)

1.27

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

0.89%

Quick Ratio(mrq)

0.89%

Book Value Per Share(mrq)

0.89

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.92

Free Cash Flow(ytd)

-8.38M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement